Dare Bioscience (DARE) Times Interest Earned (2016 - 2026)
Dare Bioscience's (DARE) quarterly Times Interest Earned came in at -$8.88 in Q4 2025, down 106.47% YoY from $137.15 in Q4 2024, and down 410.35% on a QoQ basis from -$1.74 in Q3 2025.
Dare Bioscience (DARE) Times Interest Earned (2016 - 2026) Analysis & Trends
Dare Bioscience (DARE) has 10 years of Times Interest Earned data on file, last reported at -$8.88 in Q4 2025.
- Quarterly Times Interest Earned fell 106.47% year-over-year to -$8.88 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$23.7 (up 37.82% YoY) and the FY2025 annual result came in at -$0.12, up 41.3% from the prior year.
- Times Interest Earned eased to -$8.88 in Q4 2025, from -$1.74 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $137.15 in Q4 2024 to a low of -$235.23 in Q4 2022.
- A 5-year average of -$47.13 and a median of -$51.04 in 2022 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2023 — Times Interest Earned slumped 1882.11% — and 2024, when it surged 1160.79%.
- Tracing DARE's Times Interest Earned over 5 years: stood at -$80.19 in 2021, then tumbled by 193.32% to -$235.23 in 2022, then surged by 94.5% to -$12.93 in 2023, then surged by 1160.79% to $137.15 in 2024, then slumped by 106.47% to -$8.88 in 2025.
- The last three Times Interest Earned figures came in at -$8.88 (Q4 2025), -$1.74 (Q3 2025), and -$1.81 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Dare Bioscience | 12.36 Mn | -256,055.23 | -132,343.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.21 |
| Dec 31, 2025 | -8.88 |
| Sep 30, 2025 | -1.74 |
| Jun 30, 2025 | -1.81 |
| Mar 31, 2025 | -1.78 |
| Dec 31, 2024 | 137.15 |
| Sep 30, 2024 | -20.57 |
| Jun 30, 2024 | -33.77 |
| Mar 31, 2024 | -28.80 |
| Dec 31, 2023 | -12.93 |
| Sep 30, 2023 | -79.57 |
| Jun 30, 2023 | -85.61 |
| Mar 31, 2023 | -79.83 |
| Dec 31, 2022 | -235.23 |
| Sep 30, 2022 | -88.13 |
| Jun 30, 2022 | 4.80 |
| Mar 31, 2022 | -68.30 |
| Dec 31, 2021 | -80.19 |
| Sep 30, 2021 | -108.28 |
| Jun 30, 2021 | -80.38 |